Adaptive Biotechnologies (ADPT) President and COO Sells 57,180 Shares
Julie Rubinstein, President and COO of Adaptive Biotechnologies (ADPT), sold 57,180 shares of the company's stock for approximately $826,000 between April 14 and 16, 2026. The shares were acquired through the exercise of options and immediately sold, reducing her direct ownership by 12.29%. The transaction has raised questions about its implications for the company and its leadership's confidence in the stock.
Tickers: $ADPT
Topics: executive sales SEC filings share ownership stock transactions